BRIEF-Crown Laboratories And Revance Amend A&R Merger Agreement-February 2024-www.financetom.com

BRIEF-Crown Laboratories And Revance Amend A&R Merger Agreement

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Crown Laboratories And Revance Amend A&R Merger Agreement

Jan 21, 2025 5:52 AM

Jan 21 (Reuters) - Revance Therapeutics Inc ( RVNC ):

* CROWN LABORATORIES AND REVANCE AMEND THE A&R MERGER

AGREEMENT TO

INCREASE OFFER PRICE TO $3.65 PER SHARE AND EXTEND EXISTING

TENDER OFFER

* INCREASED OFFER PRICE TO $3.65 PER SHARE, A $0.55 PER

INCREASE

* CROWN EXTENDS TENDER OFFER UNTIL FEBRUARY 4, 2025

Source text:

Further company coverage:

Previous page： EPAM Systems Shares Drop After Weak 2025 Guidance, Q1 EPS Forecast Miss Next page： Frontier Swings to Q4 Loss, Revenue Higher

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

EPAM Systems Shares Drop After Weak 2025 Guidance, Q1 EPS Forecast Miss

Feb 20, 2025

EPAM Systems Inc. ( EPAM ) is trading lower Thursday following its fourth-quarter and full-year 2024 earnings report and disappointing 2025 guidance. What To Know: In its fourth quarter, EPAM ( EPAM ) posted adjusted EPS of $2.84, beating the $2.75 Estimate, and revenue of $1.25 billion, beating the $1.21 billion estimate. However, despite solid results in the fourth quarter,...

Frontier Swings to Q4 Loss, Revenue Higher

Feb 20, 2025

04:34 PM EST, 02/20/2025 (MT Newswires) -- Frontier Communications Parent ( FYBR ) reported a Q4 net loss late Thursday of $0.47 per diluted share, swinging from earnings of $0.07 from a year earlier. Analysts polled by FactSet expected loss of $0.21. Revenue for the quarter ended Dec. 31 was $1.51 billion, up from $1.43 billion a year earlier. Analysts...

Glaukos Q4 Non-GAAP Loss Narrows, Sales Rise

Feb 20, 2025

04:33 PM EST, 02/20/2025 (MT Newswires) -- Glaukos ( GKOS ) reported a Q4 non-GAAP diluted loss late Thursday of $0.40 per share, narrowing from a loss of $0.63 a year earlier. Analysts polled by FactSet expected a loss of $0.38. Net sales for the quarter ended Dec. 31 was $105.5 million, up from $82.4 million a year earlier. Analysts...

Universal Display's Q4 Earnings Decline, Revenue Increases -- Shares Rise After Hours

Feb 20, 2025

04:36 PM EST, 02/20/2025 (MT Newswires) -- Universal Display ( OLED ) reported Q4 diluted earnings Thursday of $0.96 per share, down from $1.29 a year earlier. Analysts polled by FactSet expected $1.06. Revenue for the quarter ended Dec. 31 was $162.3 million, up from $158.3 million a year earlier. Analysts surveyed by FactSet expected $150.1 million. The company said...